43. Pharmacy (Basel). 2018 Jun 9;6(2). pii: E53. doi: 10.3390/pharmacy6020053.Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for BreastCancer: A Theory-Based Qualitative Study to Guide the Development of CommunityPharmacist Interventions.Humphries B(1)(2)(3), Collins S(4)(5), Guillaumie L(6)(7), Lemieux J(8)(9),Dionne A(10)(11)(12), Provencher L(13)(14), Moisan J(15)(16), LauzierS(17)(18)(19).Author information: (1)Population Health and Optimal Health Practices, CHU de Quebec⁻Université LavalResearch Centre, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada. humphrib@mcmaster.ca.(2)Faculty of Pharmacy, Université Laval, 1050 avenue de la Médecine, Quebec, QC G1V 0A6, Canada. humphrib@mcmaster.ca.(3)Department of Health Research Methods, Evidence and Impact, McMasterUniversity, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.humphrib@mcmaster.ca.(4)Population Health and Optimal Health Practices, CHU de Quebec⁻Université LavalResearch Centre, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada. steph1collins@hotmail.com.(5)Faculty of Pharmacy, Université de Montréal, 2940 Chemin de Polytechnique,Montréal, QC H3T 1J4, Canada. steph1collins@hotmail.com.(6)Population Health and Optimal Health Practices, CHU de Quebec⁻Université LavalResearch Centre, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada. laurence.guillaumie@fsi.ulaval.ca.(7)Faculty of Nursing, Université Laval, Quebec, 1050 avenue de la Médecine,Quebec, QC G1V 0A6, Canada. laurence.guillaumie@fsi.ulaval.ca.(8)Oncology Research Unit, CHU de Quebec⁻Université Laval Research Centre,Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada.Julie.Lemieux@crchudequebec.ulaval.ca.(9)Centre des maladies du sein Deschênes-Fabia, CHU de Quebec⁻Université Laval,Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC, G1S 4L8, Canada.Julie.Lemieux@crchudequebec.ulaval.ca.(10)Faculty of Pharmacy, Université Laval, 1050 avenue de la Médecine, Quebec, QCG1V 0A6, Canada. Anne.Dionne@pha.ulaval.ca.(11)Oncology Research Unit, CHU de Quebec⁻Université Laval Research Centre,Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada.Anne.Dionne@pha.ulaval.ca.(12)Centre des maladies du sein Deschênes-Fabia, CHU de Quebec⁻Université Laval, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC, G1S 4L8, Canada.Anne.Dionne@pha.ulaval.ca.(13)Oncology Research Unit, CHU de Quebec⁻Université Laval Research Centre,Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC G1S 4L8, Canada.louise.provencher.cha@ssss.gouv.qc.ca.(14)Centre des maladies du sein Deschênes-Fabia, CHU de Quebec⁻Université Laval, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC, G1S 4L8, Canada.louise.provencher.cha@ssss.gouv.qc.ca.(15)Population Health and Optimal Health Practices, CHU de Quebec⁻UniversitéLaval Research Centre, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec,QC G1S 4L8, Canada. jocelyne.moisan@pha.ulaval.ca.(16)Faculty of Pharmacy, Université Laval, 1050 avenue de la Médecine, Quebec, QCG1V 0A6, Canada. jocelyne.moisan@pha.ulaval.ca.(17)Population Health and Optimal Health Practices, CHU de Quebec⁻UniversitéLaval Research Centre, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec,QC G1S 4L8, Canada. sophie.lauzier@pha.ulaval.ca.(18)Faculty of Pharmacy, Université Laval, 1050 avenue de la Médecine, Quebec, QCG1V 0A6, Canada. sophie.lauzier@pha.ulaval.ca.(19)Centre des maladies du sein Deschênes-Fabia, CHU de Quebec⁻Université Laval, Hôpital du Saint-Sacrement, 1050 chemin Ste-Foy, Quebec, QC, G1S 4L8, Canada.sophie.lauzier@pha.ulaval.ca.Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces therecurrence and mortality risks among women with hormone-sensitive breast cancer. However, adherence to AET is suboptimal. To guide the development of theory-basedinterventions to enhance AET adherence, we conducted a study to explore beliefsregarding early adherence to AET. This qualitative study was guided by the Theoryof Planned Behavior (TPB). We conducted focus groups and individual interviewsamong women prescribed AET in the last two years (n = 43). The topic guideexplored attitudinal (perceived advantages and disadvantages), normative(perception of approval or disapproval), and control beliefs (barriers andfacilitating factors) towards adhering to AET. Thematic analysis was conducted.Most women had a positive attitude towards AET regardless of theirmedication-taking behavior. The principal perceived advantage was protectionagainst a recurrence while the principal inconvenience was side effects. Almosteveryone approved of the woman taking her medication. The women mentionedfacilitating factors to encourage medication-taking behaviors and cope with side effects. For adherent women, having trouble establishing a routine was their mainbarrier to taking medication. For non-adherent women, it was side effectsaffecting their quality of life. These findings could inform the development ofcommunity pharmacy-based adherence interventions.DOI: 10.3390/pharmacy6020053 PMCID: PMC6024955PMID: 29890738 